Swiss National Bank’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,500
| Closed | -$281K | – | 2415 |
|
|
2024
Q4 | $281K | Hold |
50,500
| – | – | ﹤0.01% | 2434 |
|
|
2024
Q3 | $546K | Sell |
50,500
-4,900
| -9% | -$53K | ﹤0.01% | 2419 |
|
|
2024
Q2 | $1.16M | Buy |
55,400
+1,500
| +3% | +$31.5K | ﹤0.01% | 2104 |
|
|
2024
Q1 | $1.72M | Buy |
53,900
+12,400
| +30% | +$395K | ﹤0.01% | 1922 |
|
|
2023
Q4 | $841K | Sell |
41,500
-4,600
| -10% | -$93.2K | ﹤0.01% | 2335 |
|
|
2023
Q3 | $587K | Sell |
46,100
-15,500
| -25% | -$197K | ﹤0.01% | 2470 |
|
|
2023
Q2 | $1.11M | Buy |
61,600
+23,100
| +60% | +$417K | ﹤0.01% | 2232 |
|
|
2023
Q1 | $662K | Buy |
+38,500
| New | +$662K | ﹤0.01% | 2454 |
|
|
2022
Q4 | – | Sell |
-64,600
| Closed | -$519K | – | 2690 |
|
|
2022
Q3 | $519K | Hold |
64,600
| – | – | ﹤0.01% | 2553 |
|
|
2022
Q2 | $451K | Buy |
64,600
+7,600
| +13% | +$53.1K | ﹤0.01% | 2638 |
|
|
2022
Q1 | $862K | Buy |
57,000
+3,700
| +7% | +$56K | ﹤0.01% | 2463 |
|
|
2021
Q4 | $1.17M | Buy |
53,300
+23,700
| +80% | +$520K | ﹤0.01% | 2386 |
|
|
2021
Q3 | $798K | Buy |
29,600
+9,000
| +44% | +$243K | ﹤0.01% | 2492 |
|
|
2021
Q2 | $496K | Buy |
+20,600
| New | +$496K | ﹤0.01% | 2623 |
|